This invention relates to the discovery of novel compounds, or pharmaceutically acceptable salts thereof, which possess HDAC inhibitory activity. In particular, the compounds of the invention demonstrate selectivity towards Class I HDAC enzymes, and are accordingly expected to be useful for their anti-proliferative activity and in methods of treatment of the human or animal body, for example in preventing or inhibiting tumour growth and metastasis in cancers. The invention also relates to processes for the manufacture of the compounds defined herein, or pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments for use in the production of an anti-proliferative effect in a warm-blooded animal such as man.
本发明涉及发现具有H
DAC抑制活性的新化合物或其药学上可接受的盐。特别是,本发明的化合物表现出对I类H
DAC酶的选择性,并因此预计在抗增殖活性和治疗人类或动物身体的方法中有用,例如在预防或抑制癌症中的肿瘤生长和转移。本发明还涉及制造上述化合物或其药学上可接受的盐的过程,含有它们的药物组合物以及它们在制造用于在温血动物(例如人)中产生抗增殖效应的药物中的使用。